Regulatory Incentives and Knowledge Dynamics in Pharmaceutical Innovation: Evidence from Breakthrough Therapy Designation
Pharmaceutical innovation heavily depends on scientific knowledge, but it is also shaped by regulatory institutions that define safety and efficacy requirements for market entry and influence time to market. This study examines whether the U.S. Food and Drug Administration’s Breakthrough Therapy Designation (BTD), intr...